Summaries of Court Actions are given pursuant to Section 705 of the Federal Food, Drug, and Cosmetic Act. Summaries of Court Actions report cases involving seizure proceedings, criminal proceedings, and injunction proceedings. Seizure proceedings are civil actions taken against goods alleged to be in violation, and criminal and injunction proceedings are against firms or individuals charged to be responsible for violations. The cases generally involve foods, drugs, devices, or cosmetics alleged to be adulterated or misbranded or otherwise violative of the law when introduced into and while in interstate commerce.Summaries of Court Actions are prepared by Food and Drug Division, Office of the General Counsel, HHS, and are published by direction of the Secretary of Health and Human Services.
PRODUCT: Flounder fillets, frozen, at Newport News, Va. (E.D. Va.); Civil No. 4:95CV00125.
CHARGED 9-6-95: While held for sale after shipment in interstate commerce at Top Quality Seafood, Inc., in Newport News, Va., the articles were adulterated in that they consisted of decomposed fish--402(a)(3).
DISPOSITION: A consent decree of condemnation and destruction ordered the articles destroyed. (F.D.C. No. 67104; S. No. 95-733-868; S.J. No. 2)
PRODUCT: Fresh plate fish, frozen, at Columbus, Ohio (S.D. Ohio); Civil No. C2-89-125.
CHARGED 2-13-89: While held for sale after shipment in interstate commerce at Interstate Cold Storage, Inc., in Columbus, Ohio, the articles were adulterated in that Smooth Oreo Dory was substituted for Orange Roughy--402(b)(2). The articles were misbranded in that they were offered for sale under the name of another food, and labeling failed to bear the common name of the food--403(b) and 403(i). The articles were also misbranded in that their labeling was false because the food was labeled as Orange Roughy when it was Smooth Oreo Dory--403(a)(1).
DISPOSITION: The articles were donated to a charitable organization. (F.D.C. No. 65619; S. No. 89-547-961; S.J. No. 3)
PRODUCT: Raisins, at Selma, Calif. (E.D. Calif.); Civil No. CV-F-94-5689-GEB-SSH.
CHARGED 7-5-94: While held for sale after shipment in interstate commerce at American Raisin Packers, Inc., in Selma, Calif., the articles were adulterated in that they consisted of insects, insect fragments, insect cast skins, and feather barbules--402(a)(3). The articles were misbranded in that they were manufactured from two or more ingredients, and their label failed to bear the common name of each ingredient--402(i)(2).
DISPOSITION: A consent decree ordered the articles destroyed. (F.D.C. No. 66984; S. No. 94-705-349; S.J. No. 4)
PRODUCT: Shrimp, frozen, at Tampa, Fla. (M.D. Fla.); Civil No. 95-1877-Civ-T-23(A).
CHARGED 11-14-94: While held for sale after shipment in interstate commerce at Seaboard Cold Storage, in Tampa, Fla., the articles were adulterated in that they consisted of decomposed shrimp--402(a)(3).
DISPOSITION: A consent decree of condemnation and destruction ordered the articles destroyed. (F.D.C. No. 67111; S. No. 95-713-265; S.J. No. 5)
DEFENDANT: Frank Gasper, at Tulare, Calif. (E.D. Calif.); Civil No. 96-5443-REC DLB.
CHARGED 4-29-96: The defendant introduced or caused to be introduced into interstate commerce adulterated calves for slaughter for use as food--301(a). The calves were adulterated in that they contained unsafe new animal drugs--402(a)(2)(D). The calves were also adulterated in that they were held under insanitary conditions whereby they might have been rendered injurious to health--402(a)(4).
DISPOSITION: A consent decree of permanent injunction was filed. The defendant later was found to be in compliance with the decree. (Inj. No. 1392; S. No. 95-753-841; S.J. No. 9)
ACTION: Public Citizen, Inc. v. DHHS, et al., at Washington, D.C. (D.D.C.); Civil No. 1:94CV02338.
CHARGED 10-28-94: Plaintiff charged that FDA had unreasonably delayed publishing regulations under the Safe Medical Devices Act of 1990.
DISPOSITION: While in litigation, three of the four regulations the plaintiff was suing over were published--510(k) summary/statement, civil money penalties, and medical device reporting. Plaintiff lost on the remaining claim relating to postmarket surveillance. Plaintiff was awarded a settlement under the Equal Access to Justice Act. (Misc. No. 1075; S.J. No. 11)
FDA Consumer magazine (October 1996)